Main

FDA Approvals - St. Jude Medical Announces FDA and European CE Mark Approvals


St. Jude Medical Announces FDA and European CE Mark Approvals of the IsoFlex Optim Pacing Lead (Business Wire via Yahoo! Finance)
ST. PAUL, Minn.----St. Jude Medical, Inc. today announced U.S. Food and Drug Administration and European CE Mark approvals of the IsoFlex Optim pacing lead. The small-diameter lead is built on the proven IsoFlex pacing lead platform, and features the company's exclusive Optim insulation material.

Terguride Receives FDA Orphan Drug Designation For The Treatment Of Pulmonary Arterial Hypertension (Medical News Today)
Ergonex Pharma announced that the United States Food and Drug Administration (FDA) has granted orphan drug designation to Terguride for the treatment of pulmonary arterial hypertension (PAH). Terguride is currently being evaluated for PAH in a pivotal Phase II trial in Europe.

Zydus Cadila gets four US FDA approvals (PharmaBiz)
Zydus Cadila has received four product approvals from US FDA. The group has received approvals to market Pravastatin' sodium tablets USP 10, 20, 40 and 80 mg and tentative approvals for Escitalopram Oxalate' tablets 5,10 and 20 mg, Losartan Potassium and Hydroeblorthiazide tablets 50 mgIl2.5 mg and 100 mgtl5 mg and Anastrazole tablets 1mg.

FDA Approvals - Terguride Receives FDA Orphan Drug Designation For The Treatment Of


Terguride Receives FDA Orphan Drug Designation For The Treatment Of Pulmonary Arterial Hypertension (Medical News Today)
Ergonex Pharma announced that the United States Food and Drug Administration (FDA) has granted orphan drug designation to Terguride for the treatment of pulmonary arterial hypertension (PAH). Terguride is currently being evaluated for PAH in a pivotal Phase II trial in Europe.

(AFX UK Focus) 2008-05-15 09:14 India's Zydus Cadila gets 4 product approvals from U.S. FDA (Interactive Investor)
MUMBAI (Thomson Financial) - Indian pharmaceuticals company Zydus Cadila said it received four product approvals from the U.S. Food and Drug Administration with a market size of $6.498 billion.
 
Notify me with the latest breaking FDA News
fda approvals Tell us where to send your notifications:

FDA Approvals - (AFX UK Focus) 2008-05-15 09:14 India's Zydus Cadila gets 4


(AFX UK Focus) 2008-05-15 09:14 India's Zydus Cadila gets 4 product approvals from U.S. FDA (Interactive Investor)
MUMBAI (Thomson Financial) - Indian pharmaceuticals company Zydus Cadila said it received four product approvals from the U.S. Food and Drug Administration with a market size of $6.498 billion.

Zydus Cadila gets four US FDA approvals (PharmaBiz)
Zydus Cadila has received four product approvals from US FDA. The group has received approvals to market Pravastatin' sodium tablets USP 10, 20, 40 and 80 mg and tentative approvals for Escitalopram Oxalate' tablets 5,10 and 20 mg, Losartan Potassium and Hydroeblorthiazide tablets 50 mgIl2.5 mg and 100 mgtl5 mg and Anastrazole tablets 1mg.

 

©2006 FDA-News.com. All rights reserved.